COVID-19 news from experts at Columbia University Irving Medical Center. Visit our Coronavirus Resource Center for the latest COVID-19 information for CUIMC providers, staff, students, researchers and patients. If you are a member of the media and would like to receive CUIMC COVID-19 Advances, a tip sheet for journalists produced by the CUIMC Office of Communications, please email CUMCNews@cumc.columbia.edu with the subject line "CUIMC COVID-19 Advances."
Search All News
New genetic and patient analyses suggest severe COVID is linked to overactive complement, one of the immune system’s oldest branches, and excess blood clotting.
Googling for financial issues and disaster help rose sharply early in the COVID-19 pandemic and may portend a future increase in suicides, Columbia researchers found.
Heart transplants, donor hearts, and transplant waitlists all fell sharply at the start of the COVID-19 pandemic in the United States, Columbia University researchers have found.
- March 27, 2020
Medical students at Columbia University Vagelos College of Physicians and Surgeons will graduate early and be offered temporary employment at NewYork-Presbyterian Hospital to help with COVID-19.
- March 24, 2020
Data scientists from Columbia University and around the world are starting to use the world’s electronic health records and databases to identify the best therapies for treating COVID-19 patients.
- March 23, 2020
Psychologist Anthony Puliafico offers some helpful advice for practicing self-care, helping patients problem solve, and not worrying yourself sick.
- March 16, 2020
The explosion of COVID-19 cases in China was largely driven by people with mild or no symptoms who went undetected, according to a new study from Columbia University Mailman School of Public Health.
- March 5, 2020
The National Institutes of Health has provided the Center for Infection and Immunity live SARS-CoV-2 samples to use in research to develop rapid tests and identify sources of transmission.
- February 20, 2020
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus.